Author

Marie Šulová

Masaryk UniversityORCID 0009-0005-9136-3193Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Research Focus:perturbation response prediction· 1

Frequent Co-Authors

Martin MarekiD· 2 shared Adela KubistovaiD· 1 shared Andreas Jakob· 1 shared Andrew J. deMelloiD· 1 shared Ankit JainiD· 1 shared Christoffel P. S. BadenhorstiD· 1 shared David BednářiD· 1 shared David Damborsky· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

Martin MarekORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BiochemistryACS CatalysisPeer-reviewedOct 2, 2026

Uncovering Functional Distant Mutations by Ultra-High-Throughput Screening of Dehalogenases

Hana Faldynová, David R. Kovar, Ankit Jain…·Zbyněk Prokop

This study uses ultrahigh-throughput screening to identify mutations in dehalogenases that modulate substrate access and binding, revealing distal functional effects on enzyme dynamics.

DOI 10.1021/acscatal.6c03694

proteomicsexperimental assay

𝕏 PostBluesky

Cancer BiologybioRxivPreprintOct 1, 2026

Cumate-inducible models of MYC-driven neuroblastoma identify mitoribosomal synthetic lethality as a precision oncology vulnerability in MYC(N)-amplified tumors

Adela Kubistova, I. R. Horak, Tomáš Bárta…·Jan Skoda

This paper develops a cumate-inducible model to study MYC-driven neuroblastoma and identifies mitoribosomal synthetic lethality as a therapeutic target in MYC(N)-amplified tumors.

DOI 10.64898/2026.05.25.725359

humanbulk RNA-seq

𝕏 PostBluesky